REMMHIIT-COVID: REmotely Monitored, Mobile Health-Supported High Intensity Interval Training After COVID-19 Critical Illness (REMM-HIIT-COVID-19)
Study Details
Study Description
Brief Summary
REmotely Monitored, Mobile Health-Supported High Intensity Interval Training after COVID-19 critical illness (REMM-HIIT-COVID-19)
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
REmotely Monitored, Mhealth (REMM) supported High Intensity Interval Training (HIIT to improve recovery after Intensive Care Unit (ICU) discharge in patients with COVID-19 (REMM-HIIT-ICU-COVID) will evaluate the feasibility of clinical-, physiological- and patient-centered outcomes associated with a remotely monitored, Mhealth-supported high intensity interval rehabilitation exercise training to improve the functional recovery of survivors who have experienced critical illness with COVID-19 and have been discharged home from the hospital.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: REmotely Monitored, Mhealth (REMM) supported High Intensity Interval Training (HIIT) REmotely Monitored, Mhealth (REMM) supported High Intensity Interval Training (HIIT) The intervention consists of high intensity interval training, consisting of a 30-minute exercise session that includes 10 x 1-minute intervals of high intensity 3x/week (e.g., Monday, Wednesday, Friday) and supplemented with 2 sessions per week of strength, balance, and mobility exercises (e.g., Tuesday, Thursday). Exercise will be supported by an activity tracker, which will allow study personnel to track patient heart rates during exercise on a daily basis, allowing them to provide individualized feedback and coaching. |
Behavioral: REmotely Monitored, Mhealth (REMM) supported High Intensity Interval Training (HIIT)
REmotely Monitored, Mhealth (REMM) supported High Intensity Interval Training (HIIT) The intervention consists of high intensity interval training, consisting of a 30-minute exercise session that includes 10 x 1-minute intervals of high intensity 3x/week (e.g., Monday, Wednesday, Friday) and supplemented with 2 sessions per week of strength, balance, and mobility exercises (e.g., Tuesday, Thursday). Exercise will be supported by an activity tracker, which will allow study personnel to track patient heart rates during exercise on a daily basis, allowing them to provide individualized feedback and coaching.
|
Other: Comparator Patients randomized to the control arm will receive the same technology platform and education on exercise options, including HIIT, but will return home to exercise as they see fit without personalized instruction and coaching. They will be remotely monitored, but will not receive feedback unless any adverse events are noted |
Other: Comparator
Patients randomized to the control arm will receive the same technology platform and education on exercise options, including HIIT, but will return home to exercise as they see fit without personalized instruction and coaching. They will be remotely monitored, but will not receive feedback unless any adverse events are noted
|
Outcome Measures
Primary Outcome Measures
- Peak oxygen consumption (V02P) at 3 months after hospital discharge [3 months post-discharge]
Secondary Outcome Measures
- Change in 6 minute walk test distance from baseline to 3 months after hospital discharge [Hospital discharge (baseline), 3 months post-discharge]
distance walked in 6 minutes
- Change in muscle mass from baseline to 3 months after hospital discharge [Hospital discharge (baseline), 3 months post-discharge]
Measured by muscle sound
- Change in muscle strength from baseline to 3 months after hospital discharge [Hospital discharge (baseline), 3 months post-discharge]
Measured by Fried Frailty (includes Hand Grip strength)
- Change in muscle strength from baseline to 3 months after hospital discharge [Hospital discharge (baseline), 3 months post-discharge]
Measured by quadriceps strength (Quadricep muscle dynamometry)
- Cognition at 3 months after hospital discharge [3 months post-discharge]
Measured by Repeatable Battery for Assessment of Neuropsychological Status (RBANS)
- Change in cognition from baseline to 3 months after hospital discharge. [Hospital discharge (baseline), 3 months post-discharge]
Measured by Montreal Cognitive Assessment (MOCA)
- Change in cognition from baseline to 3 months after hospital discharge. [Hospital discharge (baseline), 3 months post-discharge]
Measured by Hayling Sentence Completion
- Change in cognition from baseline to 3 months after hospital discharge. [Hospital discharge (baseline), 3 months post-discharge]
Measured by PROMIS Cognitive function
- Change in cognition from 3 months to 6 months after hospital discharge. [3 months post-discharge, 6 months post-hospital discharge]
Measured by PROMIS Cognitive function
- Change in quality of life from baseline to 3 months after hospital discharge. [Hospital discharge (baseline), 3 months post-discharge]
Measured by Sociodemographic survey
- Change in quality of life from baseline to 3 months after hospital discharge. [Hospital discharge (baseline), 3 months post-discharge]
Measured by Employment Survey
- Change in quality of life from baseline to 3 months after hospital discharge. [Hospital discharge (baseline), 3 months post-discharge]
Measured by EQ-5D-5L
- Change in quality of life from baseline to 3 months after hospital discharge. [Hospital discharge (baseline), 3 months post-discharge]
Measured by Katz ADL/ Lawton IADL
- Change in quality of life from baseline to 3 months to 6 months after hospital discharge. [3 months post-discharge, 6 months post-hospital discharge]
Measured by Sociodemographic Survey
- Change in quality of life from baseline to 3 months to 6 months after hospital discharge. [3 months post-discharge, 6 months post-hospital discharge]
Measured by Employment Survey
- Change in quality of life from baseline to 3 months to 6 months after hospital discharge. [3 months post-discharge, 6 months post-hospital discharge]
Measured by EQ-5D-5L
- Change in quality of life from baseline to 3 months to 6 months after hospital discharge. [3 months post-discharge, 6 months post-hospital discharge]
Measured by Katz ADL/ Lawton IADL
Other Outcome Measures
- Change in biomarkers of aging and resilience, and mitochondrial function from baseline to 3 months post-discharge [Hospital discharge (baseline), 3 months post-discharge]
Measured by peripheral blood mononuclear cell (PBMC)
- Change in biomarkers of aging and resilience, and mitochondrial function from baseline to 3 months post-discharge [Hospital discharge (baseline), 3 months post-discharge]
Measured by plasma
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Age >= 18 years
-
ICU admission and subsequent discharge for primary diagnosis of COVID-19 respiratory failure or infection requiring intubation and mechanical ventilation for > 48 hours with an ICU length of stay of ≥ 4 days.
-
Ability to ambulate with or without a gait aid prior to hospital discharge
-
Expected hospital discharge directly back to patient's residence (not to a skilled nursing facility, inpatient rehabilitation center, or long-term acute care hospital)
Exclusion Criteria:
-
Not ambulating independently prior to COVID-19 illness (use of a gait aid permitted)
-
Functional impairment resulting in inability to exercise at hospital discharge (including need for home oxygen requirement)
-
Unable or unwilling to follow coaching via mobile-health iPhone interaction
-
Any absolute contraindications to exercise (as outlined in the American Thoracic Society Guidelines for Cardiopulmonary Exercise Testing), including but not limited to:
-
Recent (< 5 days) acute primary cardiac event
-
Unstable Angina
-
Uncontrolled dysrhythmias causing symptoms or hemodynamic compromise
-
Symptomatic aortic stenosis
-
Uncontrolled symptomatic heart failure
-
Acute myocarditis or pericarditis
-
Suspected or known dissecting aneurysm
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Duke University Medical Center | Durham | North Carolina | United States | 27710 |
2 | Vanderbilt University | Nashville | Tennessee | United States | 37232 |
Sponsors and Collaborators
- Duke University
- Vanderbilt University
Investigators
- Principal Investigator: Paul Wischmeyer, MD, Duke University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- Pro00105798